DeepScribe Alternative for Allergy Practices — the Specialty-Fit Test

DeepScribe, like most ambient AI scribes, was built to serve every

specialty at once. That is a legitimate engineering choice — and the reason

allergists who try general scribes keep telling us the same story: the note

reads fine, but the actual allergy work still lives outside it.

Run the specialty-fit test

Take your most ordinary Tuesday and ask any scribe vendor — including us —

to walk through it end to end:

The 9:00 is a new patient with suspected environmental allergies. The

visit produces a conversation and a skin-prick order. Does the order exist

anywhere, or just a sentence about it?

The 9:40 is the skin test itself. Forty wells, control validation, a

nurse reading sizes in millimeters. A conversation-only scribe is a

spectator here. Medora runs this as a structured workflow — photo capture,

nurse review on every reading, AAAAI-aligned documentation — and the note

inherits the results because they share one patient record.

The 11:15 is an immunotherapy follow-up. The relevant history is the

build-up schedule and last month's reaction, not just today's words. Ask

where that context comes from.

The 2:30 note gets audited. Point at any line of the assessment and ask

the vendor: can you show me where this came from? Medora's Evidence Mapping

answers with the exact transcript lines. This is the feature allergists

show colleagues first.

At 5:15 the notes need signing. Every Medora draft waits for clinician

review — you review, you sign, it counts. In our pilot practice, provider

sign-off went from 18 minutes to 4 over 60 days, measured across 312 skin

tests.

Where we are honest about limits

Medora's native chart write-back and booking integration are live for IMS

Meditab practices today; on other EMRs the signed note reaches your chart

the way your current process does. If a vendor claims identical deep

integration with every EMR, ask to watch a note land in yours.

Request a demo —

we will run this exact Tuesday on a synthetic patient.